IBM Hyper Protect Accelerator is an investment-readiness and technical mentorship program, run in partnership with Village Capital and IBM. The program supports impact-focused startups leveraging highly sensitive data to improve the quality of, and access to digital, financial and healthcare services and is currently accepting applications. No equity is taken by IBM or Village Capital as part of the program. This year…
The UK Government is currently consulting on their Women’s Health Strategy and is looking for written submissions from organizations as well as feedback from individual members of the public. We’re seeking your views to help inform the development of the government’s Women’s Health Strategy. The easiest way to participate in the call for evidence as an individual is by completing the public survey.…
Contraline, a venture-backed medical device company devoted to providing men and couples with long-lasting, safe, and effective male contraception, has appointed medical device industry executive Martin Emerson to its Board of Directors. “Marty joins our Board at an exciting time as we transition to a clinical-stage organization and plan to initiate our first-in-human clinical trial of ADAM, the world’s first injectable hydrogel…
Only 2 weeks after its official launch, Vella Bioscience the company behind Vella Women’s Pleasure Serum, a clinically demonstrated pre-play topical serum that promotes increased arousal and lubrication, and more frequent, intense, and satisfying orgasms, has closed a $7 million seed II funding round, anchored by Aaron Fleck & Associates. The oversubscribed funding round puts Vella Bioscience at over $50 million post-money valuation, positioning the company to move forward on…
Famlee, a digital fertility solution, announced today thelaunch of its all-in-one at-home fertility protocol that prepares a woman’s body for baby, including 50-state fertility telehealth, 14-hormone at-home lab testing, customized prescriptions, a fertility tracking mobile app and more. One in eight women will experience fertility complications. 30-35% of these complications are attributed to hormone imbalances and another 30% of “unexplained infertility” is often…
Israel-based startup AiVF has received the European CE Mark which now allows the company to market throughout the European Union. The company has developed technology based on AI, computer vision and big data analytics to help improve iVF outcomes. Professor Daniel Seidman, MD, co-founder and Chief Medical Officer at AiVF, noted: “Traditional embryo evaluation technique is performed manually and is not AI…
Evofem today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for EVO100 for the prevention of urogenital gonorrhea in women. Fast Track designation is designed to facilitate the development and expedite the review of new therapies to treat serious conditions and fill unmet medical needs. According to a new report published by the Centers for Disease…
Aspira Women’s Health, a bioanalytical-based women’s health company focused on gynecologic disease and The Feinstein Institutes for Medical Research, the science arm of Northwell Health, the largest private Healthcare Provider in New York State, today announced the start of a prospective Clinical Study for Ovarian Cancer Risk Detection. Northwell Health treats over 2 million patients annually and employs over 16,000 credentialled physicians. The…
